🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oceaneering International director sells $75,702 in company stock

Published 11/09/2024, 22:18
OII
-

In a recent transaction on September 10, Karen H. Beachy, a director at Oceaneering International Inc. (NYSE:OII), sold 3,300 shares of the company's common stock. The sale was executed at a price of $22.94 per share, totaling approximately $75,702.


Oceaneering International Inc., known for its services in the oil and gas field, witnessed this notable transaction which was disclosed in a regulatory filing with the Securities and Exchange Commission. Following the sale, Beachy's ownership in the company now stands at 28,229 shares of common stock.


Investors often monitor insider transactions as they can provide insights into how executives and directors view the company's stock value and future performance. However, such transactions are not always indicative of future price movement and can be motivated by various personal financial considerations.


The transaction details, including the number of shares sold and the price per share, offer a glimpse into the trading activity of company insiders, which is a point of interest for the investment community.


Oceaneering International Inc. has not made any public comments regarding the transaction. The sale was reported as required by SEC regulations and provides transparency into the actions of the company's insiders.


In other recent news, Oceaneering International Inc. reported a strong Q2 performance with a net income of $35 million and revenue of $669 million. The company's consolidated bookings for the quarter exceeded $1 billion, with a manufactured products backlog of $713 million. Anticipating sequential improvements, Oceaneering projects its third quarter adjusted EBITDA to range between $95 million and $105 million. The company's strategy focuses on growth in the energy markets and expansion into non-energy sectors. For the full year of 2024, Oceaneering anticipates its consolidated adjusted EBITDA to be between $340 million and $370 million. The company also expressed optimism about growth opportunities in Brazil, Mexico, and the Gulf of Mexico. These recent developments reflect Oceaneering's commitment to its growth strategy and its anticipation of improved pricing and margins in its manufactured products business.


InvestingPro Insights


Amid the recent insider transaction at Oceaneering International Inc. (NYSE:OII), where director Karen H. Beachy sold 3,300 shares, the company's stock has been subject to market scrutiny. According to InvestingPro data, OII's market capitalization stands at $2.29 billion, with a P/E ratio of 18.37, reflecting investor sentiment about the company's earnings potential. Despite the sale, Oceaneering International has shown a robust revenue growth of 14.65% over the last twelve months as of Q2 2024, indicating a positive trajectory in its financial performance.


InvestingPro Tips suggest that OII's stock is currently in oversold territory, as indicated by the RSI, and has experienced a significant decline over the last week, with a price total return of -9.49%. Additionally, the stock is trading at a low P/E ratio relative to near-term earnings growth, which could be a signal for value investors considering the company's future profitability prospects. Notably, analysts predict the company will be profitable this year, and it has been profitable over the last twelve months.


For investors looking for more in-depth analysis, there are additional InvestingPro Tips available, which can be accessed by visiting the InvestingPro platform. These tips provide further insights into OII's financial health, such as its liquid assets exceeding short-term obligations and its moderate level of debt, which could influence investment decisions.


As the investment community weighs the implications of insider transactions, these InvestingPro Insights offer a broader context to OII's financial landscape, helping investors make more informed decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.